Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Highlights

New England Biolabs France Celebrates 10 Years!


Created “by researchers for researchers,” the scientific cooperative New England Biolabs® is recognized as the world leader in the discovery, production and supply of reagents for the life sciences industry.
To meet the enthusiastic people who accompany NEB's clients and partners in their projects ! >
NEB France celebrate 10 years @ Genopole NEB France celebrate 10 years @ Genopole

Its French affiliate arrived at Genopole in 2011 and to mark its 10th anniversary in France, the company invites you to participate in monthly activities to be held throughout 2021.

Ten years already for NEB France

Founded on the principles of ethical science, rigorous requirements to attain and maintain the best product quality possible, and a strong commitment to the environment, NEB® builds its activities on a foundation of science, people and passion.

NEB France was created in 2011 to provide its clients and partners with the highest quality services possible. It brings the innovative products developed by the parent company in the United States to the French research community.

A commitment to the environment at the heart of its activities

Logo Certified Corporation

Through sound, ecological and sustainable practices, NEB ensures the protection and preservation of natural resources, be they local or global. NEB France endeavors daily to reduce the environmental impact of its commercial processes as much as possible.

For its commitment to not only the environment but also its employees, clients and community, NEB recently earned B Corporation certificationTM.

Convinced clients, actors for change

Through its French affiliate, NEB proposes a range of innovative and renownedly efficacious products for diverse applications including NGS, nucleic acid purification, RT-qPCR and LAMP. With that offer, NEB France has won over major actors in research within Île-de-France and throughout the nation.

Genopole: a strategic and fruitful choice

NEB France launched its activities at Genopole in 2011. With its advantageous geographical location and multifold internal infrastructures, Genopole was the clear choice for capturing the Île-de-France and national markets.

With the numerous connections possible at Genopole and the proximity of the many biotechs and incubators therein, NEB France was quickly up to speed.

Stay tuned! In an upcoming podcast, NEB France Director Eric Beguec will speak on the values and commitments guiding his company and the fruitful relations his affiliate has established with other Genopole entities.  

Ten good reasons to celebrate

NEB France intends to celebrate ten years in France and at Genopole with its community. Throughout 2021, at its platform, the affiliate will propose ten participative events in the form of games or contests with such themes as education, the environment, discovery or creativity. With the events, NEB France hopes to offer its community a fun way to rediscover the company’s values and objectives.

NEB - Arts of Agar

Starting in January, the affiliate’s clients have

had the opportunity to meet the NEB team and speak about the close relations they share. In a second activity, NEB France’s clients were able to present the actions they deployed to protect and preserve the environment. Neb has also committed to making a donation to the Essonne-based Association Terre d’Avenir in their name.

With its next two events, to thank its most loyal clients, NEB France will shine a light on its laboratory talents and present a collector who possesses NEB’s oldest catalog.

 

To learn more about the past and future events for the anniversary celebrations, visit NEB France Celebrates 10 Years.

To learn more

NEB France Celebrates 10 Years

Games, contests and anecdotes; to visit the website and participate in the events >>click here.

Meet the team

To meet the enthusiastic people who accompany NEB’s clients and partners in their projects >>click here.

Stay in touch!

Subscribe to the NEB France newsletter to stay up to date on the latest information from NEB.

Article posted on 29 April 2021

Share
Highlights

Latest news


traitement des plaies diabétiques issu de peau et d’écailles de poissons

CERITD: Treating deep wounds with fish skin

CERITD and the South Île-de-France Medical Center are testing an innovative, natural fish-skin-based treatment for diabetic foot ulcers.

Discover
SYSFATE

Sysfate Team: A tool to digitize organs

Sysfate at Genoscope has combined image analysis and genomics to create MULTILAYER, a tool to digitize biological tissues and organs.

Discover
muscle fiber

Signs of myopathy detected before muscle formation

An I-Stem team has revealed very early embryonic molecular signs of Duchenne muscular dystrophy occurring upstream of muscle development itself

Discover
Neurons representation - Cells affected by CMT

Gene therapy for Charcot-Marie-Tooth disease makes headway

A gene therapy for Charcot-Marie-Tooth disease has been shown to be efficacious in an animal-model study cosigned by a research team created through Genopole support.

Discover
LAST - Makeup by Global Bioenergies

Global Bioenergies launches its makeup brand

Interview with Marc Delcourt, founder and CEO of Global Bioenergies, launches its makeup brand : LAST

Discover
Visualization and quantification by MTBench technology of protein-protein interactions observed at Opera Phenix + in a cell line.

Seeing in high resolution at the Structural Biology Platform

With the support of Genopole & the University of Évry and to enrich its technological offer, the Structural Biology Platform has acquired the Opera Phenix Plus high content screening (HCS) system.

Discover
MSCA COFUND 2020 - ApogeeBio Laureate

COFUND-MSCA2020 : ApogeeBio chosen by the EC

Submitted by Genopole and its on-site partners, the ApogeeBio project for research grants has been selected by the European Commission for Marie Skłodowska-Curie Actions co-funding (MSCA-Cofund-2020).

Discover
Genhotel -  fibroblastes, cancer & Polyarthrite

Metabolic reprogramming involved in rheumatoid arthritis and cancer

The researchers from GenHotel (University of Évry-Paris Saclay, Genopole) have shed light on certain aspects common to rheumatoid arthritis and cancer.

Discover
AB Science L. Gros

Multiple sclerosis and COVID-19: promising results from AB Science

AB Science has been announcing a series of positive results concerning the efficacy of its product, masitinib, in such pathologies as multiple sclerosis, severe asthma resistant to oral steroids, COVID-19 and amyotrophic lateral sclerosis.

Discover
Placton - Tara Oceans

Bioinformatics and Tara Oceans

A team from the Genomics Metabolics Laboratory (Genoscope – CEA/CNRS/University of Évry) has developed a bioinformatics method for environmental genomics analyses able to identify species and associations of species.

Discover
Globules rouges - Avancées scientifiques

CRISPR-Cas9 for blood and metabolic diseases – Integrare

In an article published in Nature Communications, an Integrare team headed by Dr. Mario Amendola has described an innovative genome editing strategy aimed at modifying hematopoietic stem cells.

Discover
Généthon - Genopole's Laboratory

Treating more patients with gene therapies – Généthon

A Genethon team has successfully inhibited immune response to adeno-associated virus vectors, and in so doing, opened potential paths for treating more patients with gene therapies.

Discover
COVID-19 Disease Map

A single interactive map for all that is known on COVID-19

The objective for this latter is to build a sole referential comprising the totality of scientific knowledge on SARS-CoV-2/human-host interactions and thus contribute to the identification of therapeutic possibilities.

Discover
cellular membrane

Mapping membrane nanotubes – Lambe

A team from the Genopole-accredited Laboratory for Analysis and Modeling in Biology and the Environment (Lambe) has developed an experimental technique to study cell membrane nanotubes. These largely unknown structures play an essential role in cellular biomolecule transport.

Discover
Laboratory

Toward the industrialization of gene therapies -Polytheragene

Polytheragene is developing a polymer that will improve upon the current market standards for the production of viral particles for therapeutics. The polymer will be used by Genethon and Yposkesi to enhance the bioproduction of gene therapy vectors.

Discover
Jean Weissenbach

Jean Weissenbach: a portrait

Jean Weissenbach, a pioneer in France for the exploration of the human genome and a scientific icon at Genopole, talks about his career in an interview published 18 March 2020 in CNRS News.

Discover
cellular membrane

A nanopore to identify amino acids – Lambe

A team from the Laboratory for Analysis and Modeling in Biology and the Environment (Lambe – University of Évry/University of Cergy-Pontoise/CNRS) used a natural aerolysin nanopore to successfully identify 13 of the 20 amino acids that make up proteins.

Discover
Genopole - European projects

Green light from Europe for the Genopole-coordinated project GEN.ERA

Le projet européen GEN.ERA*, coordonné par Genopole, est sélectionné par la Commission européenne. Il vise à renforcer par une coopération entre clusters, l’internationalisation d’entreprises du secteur de la génomique au-delà du continent européen.

Discover
actus

New accomplishment in gene therapies

A clinical trial for a gene therapy to treat a severe immunodeficiency has provided highly promising initial results.

Discover
View all >
With the support from